DKSH, the leading Market Expansion Services provider with a focus on Asia, has successfully obtained both the "License for Manufacturer (Secondary Packaging)" and the "License to Manufacture Preparations of Dangerous Drugs", issued by the Hong Kong Department of Health, ensuring a smooth uninterrupted continuation in the provision of our services in secondary packaging also in 2014.
HONG KONG, Feb. 5, 2014 /PRNewswire/ -- DKSH Business Unit Healthcare, the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia, fulfills the new requirements set out by the Department of Health starting in 2014 in Hong Kong for secondary packaging, an important process in the pharmaceutical value chain that ensures products are labeled and packed according to local regulations.
Since January 1, 2014, all secondary packaging activities, including labeling, re-labeling, cartooning, re-cartooning or adding additional information (including inserts) to pharmaceutical products should only be performed by holders of the "License for Manufacturer (Secondary Packaging)". The Department of Health in Hong Kong will only issue this license to Market Expansion Services providers, distributors and wholesalers who can fulfill both legal and Good Manufacturing Practices (GMP) requirements for secondary packaging. In addition, DKSH Hong Kong also secured the "License to Manufacture Preparations of Dangerous Drugs", under which a registered pharmacist is required to supervise the dangerous drugs secondary packaging process.
"We are very proud that DKSH Business Unit Healthcare in Hong Kong is among the first Market Expansion Services providers to fulfill all the new regulatory requirements and successfully passed all the on-site inspections to obtain these licenses," said Richard Holloway, Vice President, Business Unit Healthcare, DKSH Hong Kong. "Secondary Packaging is a critical step in the value chain which may affect the quality and integrity of pharmaceutical products. Since 2009, DKSH has been accredited by SGS, the world's leading certification auditing company, to fulfill WHO GMP standards for secondary packaging. We are glad to have full capabilities and to have gained accreditation to perform this service well before this is required by the government body. At the moment, over 50% of our clients rely on DKSH to provide secondary packaging services for them. We will make sure to increase that number in the future by continuously enhancing our services while complying with upcoming regulation changes."
DKSH is the leading Market Expansion Services provider with a focus on Asia. As the term "Market Expansion Services" suggests, DKSH helps other companies and brands to grow their business in new or existing markets.
Publicly listed on the SIX Swiss Exchange since March 2012, DKSH is a global company headquartered in Zurich. With 680 business locations in 35 countries -- 660 of them in Asia -- and 26,300 specialized staff, DKSH generated net sales of CHF 8.8 billion in 2012.
DKSH Business Unit Healthcare is the leading Market Expansion Services provider for healthcare companies seeking to grow their business in Asia. Custom-made offerings comprise registration and market entry studies as well as importation, customs clearance, marketing and sales to physical distribution, invoicing and cash collection. Products available through DKSH Healthcare include ethical pharmaceuticals, consumer health, over-the-counter (OTC), as well as medical devices.
With 150 business locations in 13 countries and around 9,000 specialized staff, Business Unit Healthcare serves over 160,000 customers and generated net sales of around CHF 3.7 billion in 2012.
For further information, please contact:
DKSH Hong Kong Limited
Branding and Communications Manager
Communications Manager Business Unit Healthcare
- Health Care Industry
- Hong Kong